Table 2

Multivariate linear regressions analyses of factors associated with ASDAS–CRP, BASDAI, BASFI and HAQ–AS

ASDAS–CRPBASDAIBASFIHAQ–AS
Standard coefficientRegression coefficient (95% CI)p ValueStandard coefficientRegression coefficient (95% CI)p ValueStandard coefficientRegression coefficient (95% CI)p ValueStandard coefficientRegression coefficient (95% CI)p Value
Smoker0.090.20
(0.02 to 0.38)
0.030.120.50
(0.17 to 0.83)
0.0030.080.38
(0.07 to 0.69)
0.02NSNS
Caucasian race−0.16−0.55
(−0.83 to −0.27)
<0.001−0.14−0.94
(−1.48 to −0.41)
0.001NSNSNSNS
Male sexNININSNS−0.08−0.35
(−0.65 to −0.05)
0.02−0.23−0.32
(−0.43 to −0.22)
<0.001
HLA-B27 positivity−0.10−0.22
(−0.39 to −0.04)
0.02−0.13−0.52
(−0.85 to −0.19)
0.002NSNSNSNS
Drinker−0.09−0.25
(−0.49 to −0.02)
0.04NSNSNSNSNSNS
CRPNINI0.100.16 (0.02 to 0.31)0.03NINININI
ESRNINI0.160.34 (0.13 to 0.55)0.002NINININI
MRI spine inflammatory lesionsNSNSNININSNSNINI
MRI sacroiliac joint inflammatory lesionsNINI−0.17−0.70
(−1.04 to −0.36)
<0.001−0.10−0.48
(−0.80 to −0.16)
0.04−0.08−0.11
(−0.22 to 0.00)
0.04
ASDAS–CRPNINININI0.541.16 (1.02 to 1.30)<0.0010.430.29 (0.24 to 0.34)<0.001
BASMININININI0.200.51 (0.34 to 0.68)<0.0010.140.09 (0.04 to 0.13)<0.001
  • ASDAS–CRP, ankylosing spondylitis disease activity score, C-reactive protein based; BASDAI, Bath ankylosing spondylitis disease activity index; BASFI, Bath ankylosing spondylitis functional index; BASMI, Bath ankylosing spondylitis metrology index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; HAQ–AS, health assessment questionnaire for ankylosing spondylitis; HLA, human leucocyte antigen; NI, not included in the multivariate model; NS, non-significant in multivariate analysis.